18. April 2024 | 39:24 mins.
Webinar Series
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
Our experts Dr. Stefanie Greifeneder and Irina Rebin talked about the importance, set-up and pitfalls of Research and Development Collaborations in the life sciences industry.
Download our presentation: Importance, set-up and pitfalls of R&D collaborations
In dieser Serie
Coffee Break Life Sciences | Overview page
Navigating the revised EU Urban Wastewater Treatment Directive | Coffee Break Life Sciences #1
17. Januar 2025
Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12
20. Dezember 2024
Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11
19. November 2024
Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10
20. Oktober 2024
Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9
27. September 2024
Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8
22. August 2024
Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7
18. Juli 2024
von Irina Rebin
Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6
26. Juni 2024
Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5
15. Mai 2024
von Dr. Jan W. Grawe
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18. April 2024
von Irina Rebin
Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3
20. März 2024
Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2
23. Februar 2024
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
30. Januar 2024
Would you like to receive future invitations to our webinar series?
Then sign up for our mailing list.Related Insights
Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7
von Irina Rebin
The Long and Winding Road: (Some) EU and FDA Issues to Consider with Clinical Trials and Clinical Trial Agreements
von Irina Rebin